- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 0.16 | -3.06 | -1.72 | 1.58 | 2.84 | 0.47 | N/A | - | ||
2024/9 | 0.16 | 8.98 | -2.19 | 1.43 | 3.37 | 0.47 | 0.86 | - | ||
2024/8 | 0.15 | -6.96 | -9.49 | 1.26 | 4.14 | 0.47 | 0.88 | - | ||
2024/7 | 0.16 | 2.36 | -4.03 | 1.11 | 6.3 | 0.47 | 0.88 | - | ||
2024/6 | 0.16 | 5.49 | 14.04 | 0.95 | 8.28 | 0.46 | 0.89 | - | ||
2024/5 | 0.15 | -4.05 | 13.92 | 0.79 | 7.21 | 0.48 | 0.86 | - | ||
2024/4 | 0.16 | -9.9 | 14.34 | 0.64 | 5.76 | 0.5 | 0.83 | - | ||
2024/3 | 0.17 | 2.38 | 14.65 | 0.49 | 3.3 | 0.49 | 0.84 | - | ||
2024/2 | 0.17 | 13.98 | 17.54 | 0.32 | -1.98 | 0.47 | 0.87 | - | ||
2024/1 | 0.15 | -5.85 | -17.59 | 0.15 | -17.59 | 0.51 | 0.81 | - | ||
2023/12 | 0.16 | -22.46 | -26.0 | 1.9 | -15.58 | 0.52 | 0.81 | - | ||
2023/11 | 0.2 | 25.74 | -8.14 | 1.74 | -14.49 | 0.53 | 0.79 | - | ||
2023/10 | 0.16 | -3.52 | -2.02 | 1.54 | -15.26 | 0.49 | 0.85 | - | ||
2023/9 | 0.17 | 0.84 | 0.25 | 1.38 | -16.58 | 0.5 | 0.82 | - | ||
2023/8 | 0.17 | -1.35 | -6.48 | 1.21 | -18.47 | 0.47 | 0.87 | - | ||
2023/7 | 0.17 | 21.64 | -8.58 | 1.05 | -20.09 | 0.44 | 0.94 | - | ||
2023/6 | 0.14 | 5.39 | -26.91 | 0.88 | -21.97 | 0.41 | 1.01 | - | ||
2023/5 | 0.13 | -3.69 | -12.93 | 0.74 | -20.97 | 0.42 | 0.98 | - | ||
2023/4 | 0.14 | -9.66 | -22.54 | 0.61 | -22.51 | 0.43 | 0.95 | - | ||
2023/3 | 0.15 | 4.96 | -20.43 | 0.47 | -22.5 | 0.47 | 0.89 | - | ||
2023/2 | 0.14 | -20.09 | -34.08 | 0.32 | -23.43 | 0.54 | 0.78 | - | ||
2023/1 | 0.18 | -15.46 | -12.08 | 0.18 | -12.08 | 0.61 | 0.69 | - | ||
2022/12 | 0.21 | -3.74 | 19.73 | 2.25 | 10.23 | 0.6 | 0.74 | - | ||
2022/11 | 0.22 | 34.11 | 19.64 | 2.04 | 9.32 | 0.55 | 0.8 | - | ||
2022/10 | 0.16 | -1.28 | 2.63 | 1.82 | 8.19 | 0.51 | 0.87 | - | ||
2022/9 | 0.17 | -5.93 | 12.67 | 1.65 | 8.78 | 0.53 | 0.82 | - | ||
2022/8 | 0.18 | -3.56 | 27.14 | 1.49 | 8.36 | 0.55 | 0.78 | - | ||
2022/7 | 0.18 | -2.75 | 30.62 | 1.31 | 6.23 | 0.52 | 0.82 | - | ||
2022/6 | 0.19 | 25.56 | 29.47 | 1.13 | 3.09 | 0.51 | 0.84 | - | ||
2022/5 | 0.15 | -14.32 | 14.93 | 0.94 | -0.96 | 0.52 | 0.83 | - | ||
2022/4 | 0.18 | -7.2 | -12.16 | 0.79 | -3.52 | 0.58 | 0.74 | - | ||
2022/3 | 0.19 | -13.05 | 3.28 | 0.61 | -0.71 | 0.61 | 0.74 | - | ||
2022/2 | 0.22 | 6.58 | -0.68 | 0.42 | -2.4 | 0.6 | 0.75 | - | ||
2022/1 | 0.2 | 15.12 | -4.17 | 0.2 | -4.17 | 0.57 | 0.8 | - | ||
2021/12 | 0.18 | -3.81 | -15.27 | 2.04 | -16.68 | 0.52 | 0.92 | - | ||
2021/11 | 0.18 | 15.05 | 2.42 | 1.86 | -16.81 | 0.49 | 0.97 | - | ||
2021/10 | 0.16 | 8.36 | -1.88 | 1.68 | -18.49 | 0.45 | 1.07 | - | ||
2021/9 | 0.15 | 6.15 | -18.9 | 1.52 | -19.92 | 0.43 | 1.12 | - | ||
2021/8 | 0.14 | -0.92 | -25.25 | 1.37 | -20.02 | 0.43 | 1.13 | - | ||
2021/7 | 0.14 | -3.6 | -23.63 | 1.23 | -19.39 | 0.42 | 1.15 | - | ||
2021/6 | 0.15 | 11.46 | -19.25 | 1.09 | -18.81 | 0.48 | 1.2 | - | ||
2021/5 | 0.13 | -34.52 | -31.62 | 0.95 | -18.74 | 0.51 | 1.11 | - | ||
2021/4 | 0.2 | 9.11 | 5.13 | 0.82 | -16.2 | 0.6 | 0.95 | - | ||
2021/3 | 0.18 | -16.39 | -24.0 | 0.62 | -21.39 | 0.62 | 1.06 | - | ||
2021/2 | 0.22 | 2.84 | -3.33 | 0.43 | -20.22 | 0.64 | 1.01 | - | ||
2021/1 | 0.21 | 1.78 | -32.38 | 0.21 | -32.38 | 0.6 | 1.08 | - | ||
2020/12 | 0.21 | 16.27 | -14.25 | 2.45 | -41.27 | 0.55 | 1.27 | - | ||
2020/11 | 0.18 | 10.21 | -31.98 | 2.24 | -42.94 | 0.53 | 1.33 | - | ||
2020/10 | 0.16 | -10.43 | -45.26 | 2.06 | -43.74 | 0.53 | 1.32 | - | ||
2020/9 | 0.18 | -2.15 | -43.11 | 1.9 | -43.46 | 0.55 | 1.21 | - | ||
2020/8 | 0.19 | 1.21 | -60.28 | 1.72 | -43.5 | 0.55 | 1.22 | 新冠肺炎疫情影響,導致本月無強片發行 | ||
2020/7 | 0.18 | 1.92 | -59.54 | 1.53 | -40.43 | 0.56 | 1.2 | 新冠肺炎疫情影響,導致本月無強片發行 | ||
2020/6 | 0.18 | -5.61 | -43.69 | 1.35 | -36.31 | 0.56 | 1.25 | - | ||
2020/5 | 0.19 | 0.66 | -36.05 | 1.16 | -34.99 | 0.62 | 1.12 | - | ||
2020/4 | 0.19 | -21.13 | -52.77 | 0.97 | -34.77 | 0.66 | 1.06 | 因香港得利子公司於108年底結清算及新冠肺炎影嚮導致營收下滑 | ||
2020/3 | 0.24 | 6.35 | -45.19 | 0.78 | -28.11 | 0.78 | 0.97 | - | ||
2020/2 | 0.23 | -28.06 | -25.45 | 0.54 | -16.55 | 0.79 | 0.97 | - | ||
2020/1 | 0.32 | 29.07 | -8.7 | 0.32 | -8.7 | 0.82 | 0.92 | - | ||
2019/12 | 0.24 | -7.76 | -31.42 | 4.17 | -21.63 | 0.0 | N/A | - | ||
2019/11 | 0.26 | -11.3 | -32.29 | 3.93 | -20.93 | 0.0 | N/A | - |
年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
---|---|---|---|---|---|---|---|---|---|
2024/1 | 0.15 | 2023/1 | 0.18 | 2022/1 | 0.2 | 2021/1 | 0.21 | 2020/1 | 0.32 |
2024/2 | 0.17 | 2023/2 | 0.14 | 2022/2 | 0.22 | 2021/2 | 0.22 | 2020/2 | 0.23 |
2024/3 | 0.17 | 2023/3 | 0.15 | 2022/3 | 0.19 | 2021/3 | 0.18 | 2020/3 | 0.24 |
2024/4 | 0.16 | 2023/4 | 0.14 | 2022/4 | 0.18 | 2021/4 | 0.2 | 2020/4 | 0.19 |
2024/5 | 0.15 | 2023/5 | 0.13 | 2022/5 | 0.15 | 2021/5 | 0.13 | 2020/5 | 0.19 |
2024/6 | 0.16 | 2023/6 | 0.14 | 2022/6 | 0.19 | 2021/6 | 0.15 | 2020/6 | 0.18 |
2024/7 | 0.16 | 2023/7 | 0.17 | 2022/7 | 0.18 | 2021/7 | 0.14 | 2020/7 | 0.18 |
2024/8 | 0.15 | 2023/8 | 0.17 | 2022/8 | 0.18 | 2021/8 | 0.14 | 2020/8 | 0.19 |
2024/9 | 0.16 | 2023/9 | 0.17 | 2022/9 | 0.17 | 2021/9 | 0.15 | 2020/9 | 0.18 |
2024/10 | 0.16 | 2023/10 | 0.16 | 2022/10 | 0.16 | 2021/10 | 0.16 | 2020/10 | 0.16 |
N/A | N/A | 2023/11 | 0.2 | 2022/11 | 0.22 | 2021/11 | 0.18 | 2020/11 | 0.18 |
N/A | N/A | 2023/12 | 0.16 | 2022/12 | 0.21 | 2021/12 | 0.18 | 2020/12 | 0.21 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債 QoQ YoY | |||
---|---|---|---|
24Q3 (20) | 0.07 | 0.0 | 16.67 |
24Q2 (19) | 0.07 | 40.0 | -12.5 |
24Q1 (18) | 0.05 | 66.67 | 25.0 |
23Q4 (17) | 0.03 | -50.0 | 0.0 |
23Q3 (16) | 0.06 | -25.0 | 20.0 |
23Q2 (15) | 0.08 | 100.0 | 0.0 |
23Q1 (14) | 0.04 | 33.33 | -20.0 |
22Q4 (13) | 0.03 | -40.0 | -70.0 |
22Q3 (12) | 0.05 | -37.5 | -50.0 |
22Q2 (11) | 0.08 | 60.0 | -42.86 |
22Q1 (10) | 0.05 | -50.0 | -64.29 |
21Q4 (9) | 0.1 | 0.0 | -44.44 |
21Q3 (8) | 0.1 | -28.57 | -33.33 |
21Q2 (7) | 0.14 | 0.0 | 55.56 |
21Q1 (6) | 0.14 | -22.22 | 75.0 |
20Q4 (5) | 0.18 | 20.0 | 12.5 |
20Q3 (4) | 0.15 | 66.67 | 0.0 |
20Q2 (3) | 0.09 | 12.5 | 0.0 |
20Q1 (2) | 0.08 | -50.0 | 0.0 |
19Q4 (1) | 0.16 | 0.0 | 0.0 |